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Summary
One hundred and forty acute corneal rejection episodes in 94 patients were studied retrospectively. Sixteen episodes in 15 eyes were associated with raised intraocular pressure (lOP) on admission, three of whom had had previously elevated lOP. At six weeks, six (37.5%) stH required hypotensive therapy. Five eyes with raised lOP at rejection had lost vision at six weeks. Five of the six eyes with graft failure at review had raised lOP either pre-graft, at rejection or at follow-up. Eyes grafted for herpes simplex keratitis with hypertensive rejection episodes had a higher mean admission lOP, with a more short-lived rise than other eyes.
Glaucoma is a common cause of visual loss after penetrating keratoplasty in both phakic and aphakic patients.1�11 The reported inci dence of glaucoma in aphakic eyes after ker� atoplasty ranges from 25% to 70% and glaucoma may be more likely to persist or worsen if there was evidence of raised pres sure pre-operatively. The overall inci dence may be as high as 30%.2 Sustained increases in intraocular pressure (lOP) are known to affect the corneal endothelium adversely. Decreased endothelial cell func� tion and increased endothelial cell loss have been reported in the presence of elevated lOP in both experimental animal models and in human subjects with acute angle closure glau coma.13.14 A study of animal models with and without penetrating keratoplasty suggests that the endothelium of graft tissue is more susceptible to damage by raised lOP than normal, non-grafted, corneal endothelium. 13 The criteria for diagnosis of graft rejection included a Khodadoust line, keratic precpi tates, flare and cells, Krachmer's spots, and unexplained graft oedema. From the records of these patients we obtained data on the indication for corneal grafting and the pres ence of pre-operative glaucoma. The lOP, best corrected visual acuity and the ocular therapy on admission were recorded. Similar data were recorded at six weeks after rejec tion and the corneal graft status was also noted. If the lOP was elevated on admission, the duration of the rise and its treatment were recorded.
Results
One hundrend and forty rejection episodes in 94 patients (46 male and 48 female) with an age range of 21 to 96 years were identified. The indications for corneal grafting are pre sented in Figure L from which it can be seen that the two commonest conditions requiring keratoplasty were keratoconus and herpes N.22 Others N • 23 including 3 eyes reg rafted during study simplex keratitis, with 22 eyes grafted for ker atoconus and 20 grafted for HSV. These two groups had an almost identical number of rejection episodes with 31 for keratoconus and 30 for herpes simplex keratitis. It is interesting to compare this with the common est reasons for keratoplasty which in this insti tution between 1985-1987 were keratoconus (34.2%) and regrafts (17.2%) with viral kera titis accounting for 3.2% of grafts. L' This is illustrated in Figure 2 . Forty-one eyes (58 rejection episodes) had been grafted for a variety of disorders including interstitial kera titis, trauma, corneal dystrophies and buph thalmos. Because of their particular problems regrafts were included as a separate group (14 eyes and 21 rejection episodes). Three eyes were regrafted during the course of the study and were included in both other and regraft diagnostic groups. Thirty-nine rejection epi sodes (27.8%) occurred in those with a pre viously documented elevated lOP. None of these rejection episodes were in tissue matched grafted material. Very few kerato plasties in this institution involve tissue matched grafts, and in the previous survey less than 1 '}'o 
Increased intraocular pressure at presentation
Sixteen episodes (11.4% ) of corneal graft rejection were associated with an acute rise in lOP to 22 mmHg or higher. Of these sixteen episodes four were in regrafts, three in grafts for herpes simplex keratitis, two in keratoco nus grafts, two in grafts for Fuch's dystrophy, and the rest came from the others category and included one episode for an infective graft, another for idiopathic bullous kera topathy, one grafted, elsewhere, for unknown reasons. There were two hypertensive rejec tion episodes in one patient who had been grafted for bullous keratopathy after previous drainage surgery for chronic simple glau coma. Six of these were still requiring hypo tensive therapy at six weeks follow-up, when four were on topical therapy alone and two on a combination of topical and systemic therapy (Fig. 3 ). The patient with two rejection epi sodes and previous glaucoma used topical treatment at follow-up after both episodes. Three episodes associated with elevated lOP at the time of admission occurred in aphakic grafts. Of the four hypertensive rejec tion episodes in regrafts, one was also aphakic. The three hypertensive rejection episodes that occurred in grafts for herpes simplex keratitis had a higher admission lOP with a mean of 40 mmHg compared to the others (26.7 mmHg), but this difference is not significant (Student's t-test). Of these 16 epi sodes at the time of rejection, four had not been on topical steroids, eight had been on steroid drops four times per day or less, and only four had been on more frequent treat ment to prevent graft rejection.
Increased intraocular pressure during treatment
More patients required hypotensive medi cation at six weeks than on admission. Usually this treatment was commenced during their out-patient follow-up. Twenty-seven episodes of graft rejection (19.3%) required hypoten sive therapy at six weeks, 20 on topical hypo tensives and seven requiring combination systemic and topical therapy for lOP control ( Fig. 4) . Of these 27 episodes with high lOP at six weeks, 13 (48% ) were in patients with documented elevation of lOP prior to rejec tion. Patients with a histor y of elevated lOP titis, only one required hypotensive therapy at the six-week follow-up. This was a patient with previously elevated lOP. No patient had required surgical treatment for control of ele vated pressure by the six-week follow-up period.
Visual acuity
Twenty-four episodes of graft rejection (17% of the total rejection episodes) were followed by a recorded decrease in best corrected visual acuity of one line or greater on the Snel len chart at the six-week follow-up. Nineteen of these 24 episodes had normal lOP at the time of graft rejection, (15.3% of the 124 epi sodes without raised pressure at rejection). The other five episodes had raised lOP at the time of rejection (3 1.2% of the group with hypertensive rejection episodes). This is illus trated in Figure 5 .
Of the 19 normotensive rejection episodes, five who had not required hypotensive treat ment on admission were using hypotensive treatment (three on topical therapy alone and two requiring systemic therapy) at review. Of the five hypertensive rejections only one required treatment, topically, at follow-up.
Only one of these hypertensive episodes was associated with loss of more than two Snellen lines when vision went from 1/60 to percep tion of light due to a retinal detachment.
Graft survival
Six grafts failed as a result of rejection although only four lost vision since the other two had poor but unchanged vision (CF). Tw o grafts failed in patients with hypertensive graft rejection episodes. One of these patients who had a pressure on admission of 38 mmHg. progressed to phthisis bulbi with an underlying retinal detachment, (see above). The other patient whose graft failed had been regrafted for aphakic bullous kera topathy. He had no previous history of glau coma, had an admission lOP of 23 mmHg, and did not require hypotensive therapy at six weeks. Of the four normotensive rejection episodes to be followed by total graft failure. three had a history of raised pressure. and two were on anti-hypertensive treatment at follow-up.
Discussion
We can only find one paper in the English lan-guage literature postulating a link hetween graft rejection and glaucoma. 16 Four cases of corneal allograft rejection were descrihed associated with elevated intraocular pressure. It was suggested that increased lOP at the time of rejection was likely to be related to increased prostaglandins. inflammatory cells. pigment and fibrin in the anterior chamber. This would be expected to settle as the rejec tion episode was controlled. Prolonged ele vation of the lOP could be a consequence of the steroids used for the control of the rejec tion episode. Because of the damage that can be done to an endothelium already compro mised by the rejection mechanism the need for monitoring lOP in graft rejection was stressed.
lOP on admission
Our study has shown that corneal graft rejec tion was associated with an elevation in lOP at the time of admission in 11.4% of cases. Of these 16 episodes seven required antiglau coma medication at the six-week follow-up. Three episodes occurred in two patients with previously evelated lOP. one of whom had had previous drainage surgery for chronic simple glaucoma. It has been suggested that mild to moderate increases in lOP (hetween 30 and 40 mmHg) associated with rejection episodes and possibly steroid induced will set-' tie and that the antiglaucoma therapy can be stopped as the steroid therapy is reduced. Sig nificant increases in lOP of 40 mmHg or greater may be associated with a previous history of anterior segment inflilmmation where the outflow channels are obstructed by pigment and debris, These cases may require long-term antiglaucoma therapy. 16 We cannot confirm this impression. In our study the high est lOP in association with rejection episodes >40 mmHg were in patients grafted for her pes simplex keratitis or infection. Of 30 rejec tion episodes in patients grafted for herpes simplex corneal scarring (a potent cause of anterior segment inflammation) only one patient required hypotensive therapy at six weeks. This patient had a history of glaucoma prior to keratoplasty.
lOP during treatment
This study also demonstrates that lOP may become raised in the course of treatment of a rejection episode. The six-week review was chosen as all patients were still attending for regular follow-up at this time. Bourne indi cates that elevated lOP persisting this long after an incident is likely to be permanent. 7 This is probably a different mechanism to that associated with the acute rejection episode.
Twenty-seven of 140 (19.3'/'0) cases of graft rejection required antiglaucoma medication at six weeks. Of these 13 (48% ) were in patients with previously documented pre graft elevations in lOP. The cause of the ele vated lOP at six weeks may be related to further compromise of the outflow of the eye. damaged at the time of the initial disease pro cess or at the time of grafting. by the inflam matory debris and mediators produced by the rejection episode itself. A steroid response may also be responsible for raised lOP. That more patients with previously documented glaucoma were requiring hypotensive t\;lerapy at six weeks supports this hypothesis. A ste roid response is known to be more common in patients with primary open angle glaucoma than in non-glaucoma patients. Cortico steroids are essential to reverse the graft rejection process but the lOP must be closely monitored and a ' ny elevation treated. to mini mize further damge to corneal endothelium already compromised by the rejection process.
Herpes simplex keratitis
It is well documented that elevation of lOP may accompany herpes simplex uveitis and this trend to higher admission lOP levels of the herpes group compared with the other diagnostic categories emphasises the difficulty in differentiating early corneal graft rejection from a recurrence of herpes simplex kerato uveitis in these patients, 1 7 It is also interesting to note that the only one of the 30 rejection episodes in patients (3.3%) grafted for herpes simplex requiring hypotensive treatment at six weeks was in a patient with previously ele vated lOP. compared with 26 of 110 episodes (23.6°/r,) with other pre-graft diagnoses. This difference is significant (p<O,005) and sug gests that any rise in lOP associated with a herpetic graft rejection episode is short lived. It may be related more to inflammatory debris in the angle or a 'trabeculitis' than to a steroid induced glaucoma.
Prognosis
Raised lOP in association with a rejection may be a bad prognostic sign since of the 16 patients with elevated lOP on admission for corneal graft rejection five were documented to have lost vision by six weeks. This is 31.2% of the hypertensive group who lost vision at follow-up. Although the figures are small particularly in the hypertensive group it does appear that a rise in lOP at the time of acute corneal allograft rejection leads to an increased risk of a reduction in visual acuity.
The presumption that elevated lOP dam ages corneal endothelium and that this may shorten the life of the graft is suggested by analysis of the six rejection episodes that were followed by graft failure. All of these patients were aphakic or pseudophakic. Five of the six total graft failures were in patients with ele vated lOP occurring either pre-graft, at the time of graft rejection or at six weeks fol low-up suggesting that lOP does influence graft survival. It would appear that in the short term, elevation of lOP during the graft rejection episode may be associated with a reduction in visual acuity, and that a history of pressure elevation in association with a cor neal graft does increase the likelihood of graft failure. Aphakic or pseudophakic patients comprised five of the six graft failures empha sising the high risk of graft fail ure in this group of patients.
Conclusions
This study has clearly demonstrated an associ ation between a sudden rise in lOP and graft rejection episodes. It suggests that a sudden rise in lOP in an eye with a penetrating ker atoplasty might indicate a developing rejec tion episode and care should be taken in the supervision of such a patient. This sign should not be overlooked.
In our study corneal allograft rejection was accompanied by an increase in lOP in 11.4% of cases. We feel therefore that a sudden unexplained rise in intraocular pressure should be considered as part of the spectrum of signs of acute corneal graft rejection. Of those cases with elevated lOP on admission 43.75% still required therapy at six weeks. Patients grafted for herpes simplex keratitis appeared to have a marked but short lived rise in lOP which may reflect the difficulty in dis tinguishing between graft rejection and a recurrence of herpes simplex kerato-uveitis.
In the short follow-up of this study 31.2% of the group with elevated pressure at the time of rejection lost acuity. Five of six total graft fail ures were in patients with elevated JOP, either pre-graft, on admission, or at six weeks sug gesting that lOP control is important for long term survival of the graft.
From our findings raised intraocular pres sure in the presence of a corneal graft is a poor prognostic factor for graft survival, and hypertension at the time of graft rejection is followed by a higher chance of reduced acuity in the short term. We would emphasise the need for meticulous monitoring and control of intraocular pressure in patients with corneal grafts, especially those with aphakia or regrafts.
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